Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
about
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive ReviewTreatment of autoimmune hemolytic anemiasRituximab in the treatment of autoimmune haemolytic anaemiaEfficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.Rituximab efficacy in the treatment of children with chronic immune thrombocytopenic purpura.A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.How we manage immune thrombocytopenia in the elderly.Use of rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomasWarm autoimmune hemolytic anemia: experience from a single referral center in Mexico City.Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.B-cell targeted therapeutics in clinical development.Immunotherapy treatments of warm autoimmune hemolytic anemia.Current treatment strategies in autoimmune hemolytic disorders.Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report.A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.Acute autoimmune hemolytic anemia due to anti-Ena autoantibody successfully treated with rituximab.Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA.
P2860
Q26773178-ADBC3043-FFA8-4570-A335-09A966CAD8CAQ26866954-247563E1-5C5D-4BA4-97AB-C4BE2E48A658Q27023114-48F118D8-0310-41BA-86C8-5635D61FF46AQ33395961-0601497B-6873-43F3-977A-6CAF7EAD6D58Q33416359-63208F9A-3089-4A76-AFF0-44E8F71C88D0Q33419712-BF35C2D2-AC3D-4A31-A64D-F2C3CAC1E50BQ33431371-A9B773C2-137B-4D3F-ABAE-A31A412659E7Q34922723-4FFC3CCD-ADED-4989-B2A5-5270AA54242FQ37740414-622D1675-9871-412A-B9E1-69D175DAEFCAQ37843939-A5D0BF38-9724-4E5C-BD3E-D5EF598DEF06Q38097162-EC8C9554-86F4-46A2-8E62-A20657B4C177Q38150845-B3A71DE7-FEEE-4E9B-9CE8-1C35F37034D6Q38581833-B6E58B4A-8AA3-4BCE-98AC-D375F2C0CEEDQ39182043-66A52407-64DD-4D14-8D13-5E262BEE2032Q41791356-E05A5012-FA52-4D20-8463-F9ACEA4871EFQ47690234-40FAA985-282F-4FCB-817F-9F76AA5C21B6Q50098670-11F456FF-7172-4AD8-B315-5F5985F27130Q53798218-951CE5AB-3F0F-4BE1-B30A-53230BA5E301
P2860
Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Rituximab in auto-immune haemo ...... rospective multicentric study.
@ast
Rituximab in auto-immune haemo ...... rospective multicentric study.
@en
type
label
Rituximab in auto-immune haemo ...... rospective multicentric study.
@ast
Rituximab in auto-immune haemo ...... rospective multicentric study.
@en
prefLabel
Rituximab in auto-immune haemo ...... rospective multicentric study.
@ast
Rituximab in auto-immune haemo ...... rospective multicentric study.
@en
P2093
P1476
Rituximab in auto-immune haemo ...... rospective multicentric study.
@en
P2093
A Delannoy
A Janssens
A Van Hoof
P304
P356
10.1111/J.1365-2796.2009.02126.X
P407
P577
2009-04-27T00:00:00Z